Search

Your search keyword '"Borogovac A"' showing total 322 results

Search Constraints

Start Over You searched for: Author "Borogovac A" Remove constraint Author: "Borogovac A"
322 results on '"Borogovac A"'

Search Results

1. VERA: Validation and Evaluation of Retrieval-Augmented Systems

2. Meta Knowledge for Retrieval Augmented Large Language Models

3. Novel approach to root functions of matrix polynomials with applications in differential equations and meromorphic matrix functions

4. Green's boundary relation model in a Krein space

7. Characterization of Weyl functions in the class of operator-valued generalized Nevanlinna functions

10. Reducibility of self-adjoint linear relations and application to generalized Nevanlinna functions

11. Inverse of generalized Nevanlinna function that is holomorphic at infinity

13. Absolute Lymphocyte Count and Outcomes of Multiple Myeloma Patients Treated with Idecabtagene Vicleucel: The US Myeloma Immunotherapy Consortium Real- World Experience

14. Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of real-world outcomes

17. COVID19 infection in a patient undergoing treatment for Paroxysmal Nocturnal Hemoglobinuria (PNH) with Ravulizumab

19. Two Applications of Brouwer's Fixed Point Theorem: in Insurance and in Biology Models

20. P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

21. Eculizumab Treatment Outcomes in Patients with Allogeneic Hematopoietic Cell Transplant (alloHCT)-Associated Thrombotic Microangiopathy (TA-TMA): A Retrospective Single-Center Experience

22. Desirable Decompositions of Generalized Nevanlinna Functions

23. Characterizations of generalized poles by pole cancellation functions of higher order

26. P1079: COMPARISON OF NOVEL SALVAGE REGIMENS AND TRADITIONAL SALVAGE CHEMOTHERAPY IN RELAPSED AND REFRACTORY CLASSIC HODGKIN LYMPHOMA

27. Thrombotic Microangiopathy After Hematopoietic Stem Cell and Solid Organ Transplantation: A Review for Intensive Care Physicians.

30. A Control Variate Approach for Improving Efficiency of Ensemble Monte Carlo

31. P-018 Prior BCMA-directed bispecific antibody or CAR T is not associated with increased risk of early infections in patients treated with bispecific antibodies

32. P-347 Longitudinal profiling identifies genetic mechanisms of resistance to four different drug classes in a t(4;14) positive patient

33. Reducibility of Self-Adjoint Linear Relations and Application to Generalized Nevanlinna Functions

34. CHARACTERIZATION OF WEYL FUNCTIONS IN THE CLASS OF OPERATOR-VALUED GENERALIZED NEVANLINNA FUNCTIONS.

36. Effect of cumulative dose of brentuximab vedotin maintenance in relapsed/refractory classical Hodgkin lymphoma after autologous stem cell transplant: an analysis of realworld outcomes

38. Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival

39. Morbidities and mortality in patients with hereditary thrombotic thrombocytopenic purpura

40. A Case of Acute Myeloid Leukemia Harboring a Rare Three-Way Translocation t(5;7;7) Involving the PDGFRB Gene and Successfully Treated with Imatinib

42. Real World Outcomes of Brentuximab Vedotin Maintenance after Autologous Stem Cell Transplant in Relapsed/Refractory Classical Hodgkin Lymphoma: An Time-Variable Analysis of the Effect of Dose on Progression Free Survival

44. P102: Comparison of Novel Salvage Regimens and Traditional salvage Chemotherapy in Relapsed and Refractory Classic Hodgkin Lymphoma

Catalog

Books, media, physical & digital resources